CREO MEDICAL financials
A multi-period view of the public annual-account figures reported for CREO MEDICAL, with comparable measures and links to available source documents.
Company overviewRegistry number
0443933069
Fiscal coverage
2024–2025
Public sources
cbso_bulk
Data updated
Jul 28, 2026
Financial evidence
Latest movements for CREO MEDICAL
2025 versus 2024
- Operating line
- €1,951,612
- EBITDA
- €682,815
- Total assets
- €4,308,725
- Equity
- €3,597,397
+13.2%
+150.5%
+8.8%
+17.6%
EBITDA margin +35% · Equity ratio +83.5%
Multi-year filings
Source: NBB/CBSOFiled annual accounts by fiscal year
Public regulator-filed figures across 2 years.
Fiscal year | Gross margin | EBITDA | Total assets | Equity | Filing |
|---|---|---|---|---|---|
| 202531 Dec 2025 | €1,951,612 | €682,815 | €4,308,725 | €3,597,397 | - |
| 202431 Dec 2024 | €1,723,475 | €272,548 | €3,960,217 | €3,059,243 | - |
Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.